Morning Market Losers
March 27, 2015 at 09:57 AM EDT
Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) shares dropped 65.64% to $3.00 on failure to reach goal in OHR-102 Phase II study. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.